Hill AVS - Search Results

1

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, Blane B, Bonsall D, Cicconi P, Charlton S, Clutterbuck EA, Collins AM, Cox T, Darton TC, Dold C, Douglas AD, Duncan CJA, Ewer KJ, Flaxman AL, Faust SN, Ferreira DM, Feng S, Finn A, Folegatti PM, Fuskova M, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hallis B, Heath PT, Hay J, Hill HC, Jenkin D, Kerridge S, Lazarus R, Libri V, Lillie PJ, Ludden C, Marchevsky NG, Minassian AM, McGregor AC, Mujadidi YF, Phillips DJ, Plested E, Pollock KM, Robinson H, Smith A, Song R, Snape MD, Sutherland RK, Thomson EC, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Williams CJ, Hill AVS, Lambe T, Gilbert SC, Voysey M, Ramasamy MN, Pollard AJ; COVID-19 Genomics UK consortium; AMPHEUS Project; Oxford COVID-19 Vaccine Trial Group. Emary KRW, et al. Among authors: hill hc, hill avs. Lancet. 2021 Apr 10;397(10282):1351-1362. doi: 10.1016/S0140-6736(21)00628-0. Epub 2021 Mar 30. Lancet. 2021. PMID: 33798499 Free PMC article. Clinical Trial.

2

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

Gilbert SC, Schneider J, Hannan CM, Hu JT, Plebanski M, Sinden R, Hill AV. Gilbert SC, et al. Vaccine. 2002 Jan 15;20(7-8):1039-45. doi: 10.1016/s0264-410x(01)00450-9. Vaccine. 2002. PMID: 11803063

3

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.

Behboudi S, Moore A, Gilbert SC, Nicoll CL, Hill AV. Behboudi S, et al. Vaccine. 2004 Oct 22;22(31-32):4326-31. doi: 10.1016/j.vaccine.2004.04.029. Vaccine. 2004. PMID: 15474725

4

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.

Vuola JM, Keating S, Webster DP, Berthoud T, Dunachie S, Gilbert SC, Hill AV. Vuola JM, et al. J Immunol. 2005 Jan 1;174(1):449-55. doi: 10.4049/jimmunol.174.1.449. J Immunol. 2005. PMID: 15611270

5

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.

Bejon P, Andrews L, Andersen RF, Dunachie S, Webster D, Walther M, Gilbert SC, Peto T, Hill AV. Bejon P, et al. J Infect Dis. 2005 Feb 15;191(4):619-26. doi: 10.1086/427243. Epub 2005 Jan 7. J Infect Dis. 2005. PMID: 15655787 Clinical Trial.

6

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.

Hutchings CL, Gilbert SC, Hill AV, Moore AC. Hutchings CL, et al. J Immunol. 2005 Jul 1;175(1):599-606. doi: 10.4049/jimmunol.175.1.599. J Immunol. 2005. PMID: 15972697

7

Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.

Andrews L, Andersen RF, Webster D, Dunachie S, Walther RM, Bejon P, Hunt-Cooke A, Bergson G, Sanderson F, Hill AV, Gilbert SC. Andrews L, et al. Am J Trop Med Hyg. 2005 Jul;73(1):191-8. Am J Trop Med Hyg. 2005. PMID: 16014857

8

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

Gilbert SC, Moorthy VS, Andrews L, Pathan AA, McConkey SJ, Vuola JM, Keating SM, Berthoud T, Webster D, McShane H, Hill AV. Gilbert SC, et al. Vaccine. 2006 May 22;24(21):4554-61. doi: 10.1016/j.vaccine.2005.08.048. Epub 2005 Aug 24. Vaccine. 2006. PMID: 16150517 Review.

9

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.

Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV. Moore AC, et al. J Immunol. 2005 Dec 1;175(11):7264-73. doi: 10.4049/jimmunol.175.11.7264. J Immunol. 2005. PMID: 16301631

10

Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and underestimates parasite density.

Bejon P, Andrews L, Hunt-Cooke A, Sanderson F, Gilbert SC, Hill AV. Bejon P, et al. Malar J. 2006 Nov 8;5:104. doi: 10.1186/1475-2875-5-104. Malar J. 2006. PMID: 17092336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters